The effect of soy-derived isoflavones over hot flushes, menopausal symptoms and mood in climacteric women with increased body mass index

References

• Bhavnani BR, Strickler RC. Menopausal hormone therapy. J Obstet Gynaecol Can 2005;27:137–162.
   PubMedGoogle Scholar
• Castelo-Branco C, Rostro F. Management of menopause. Minerva Ginecol 2006;58:137–152.
   PubMedGoogle Scholar
• Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, et al Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321–333.
   PubMed Web of Science ®Google Scholar
• Blumel JE, Castelo-Branco C, Chedraui PA, Binfa L, Dowlani B, Gomez MS, Sarra S. Patients' and clinicians' attitudes after the Women's Health Initiative study. Menopause 2004;11:57–61.
   PubMed Web of Science ®Google Scholar
• Ettinger B, Grady D, Tosteson AN, Pressman A, Macer JL. Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol 2003;102:1225–1232.
   PubMed Web of Science ®Google Scholar
• Lazar F Jr, Costa-Paiva L, Morais SS, Pedro AO, Pinto-Neto AM. The attitude of gynecologists in Sao Paulo, Brazil 3 years after the Women's Health Initiative study. Maturitas 2007;56: 129–141.
   PubMed Web of Science ®Google Scholar
• Nassar AH, Abd Essamad HM, Awwad JT, Khoury NG, Usta IM. Gynecologists' attitudes towards hormone therapy in the post ‘Women's Health Initiative’ study era. Maturitas 2005; 52:18–25.
   PubMed Web of Science ®Google Scholar
• Miksicek RJ. Commonly occurring plant flavonoids have estrogenic activity. Mol Pharmacol 1993;44:37–43.
   PubMed Web of Science ®Google Scholar
• Miksicek RJ. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J Steroid Biochem Mol Biol 1994;49:153–160.
   PubMed Web of Science ®Google Scholar
• Dornstauder E, Jisa E, Unterrieder I, Krenn L, Kubelka W, Jungbauer A. Estrogenic activity of two standardized red clover extracts (menoflavon) intended for large scale use in hormone replacement therapy. J Steroid Biochem Mol Biol 2001;78:67–75.
   PubMed Web of Science ®Google Scholar
• Rees M. Alternative treatments for the menopause. Best Pract Res Clin Obstet Gynaecol 2009;23:151–161.
   PubMed Web of Science ®Google Scholar
• Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med 2006;166:1453–1465.
   PubMed Web of Science ®Google Scholar
• Cheema D, Coomarasamy A, El-Toukhy T. Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review. Arch Gynecol Obstet 2007;276:463–469.
   PubMedGoogle Scholar
• Bitto A, Altavilla D, Bonaiuto A, Polito F, Minutoli L, Di Stefano V, Giuliani D, Guarini S, Arcoraci V, Squadrito F. Effects of aglycone genistein in a rat experimental model of postmenopausal metabolic syndrome. J Endocrinol 2009;200: 367–376.
   PubMed Web of Science ®Google Scholar
• Farina HG, Pomies M, Alonso DF, Gomez DE. Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol Rep 2006;16:885–891.
   PubMed Web of Science ®Google Scholar
• Gallo D, Zannoni GF, Apollonio P, Martinelli E, Ferlini C, Passetti G, Riva A, Morazzoni P, Bombardelli E, Scambia G. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile. Menopause 2005;12:589–600.
   PubMedGoogle Scholar
• Hidalgo LA, Chedraui PA, Morocho N, Alvarado M, Chavez D, Huc A. The metabolic syndrome among postmenopausal women in Ecuador. Gynecol Endocrinol 2006;22:447–454.
   PubMed Web of Science ®Google Scholar
• Chedraui P, Pérez-López FR, Morales B, Hidalgo L. Depressive symptoms among climacteric women are related to menopausal symptom intensity and partner factors. Climacteric 2009;12:395–403.
   PubMed Web of Science ®Google Scholar
• Chedraui P, Aguirre W, Hidalgo L, Fayad L. Assessing menopausal symptoms among healthy middle aged women with the Menopause Rating Scale. Maturitas 2007;57:271–278.
   PubMed Web of Science ®Google Scholar
• Sierra B, Hidalgo LA, Chedraui PA. Measuring climacteric symptoms in an Ecuadorian population with the Greene Climacteric Scale. Maturitas 2005;51:236–245.
   PubMed Web of Science ®Google Scholar
• Chedraui P, Hidalgo L, Chavez D, Morocho N, Alvarado M, Huc A. Quality of life among postmenopausal Ecuadorian women participating in a metabolic syndrome screening program. Maturitas 2007;56:45–53.
   PubMed Web of Science ®Google Scholar
• Hidalgo LA, Chedraui PA, Morocho N, Ross S, San Miguel G. The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study. Gynecol Endocrinol 2005;21:257–264.
   PubMed Web of Science ®Google Scholar
• http://www.menopause-rating-scale.info/documents/Ref_Values_CountrGr.pdf. Last accessed 20 June 2008.
   Google Scholar
• Heinemann LA, Potthoff P, Schneider HP. International versions of the Menopause Rating Scale (MRS). Health Qual Life Outcomes 2003;1:28.
   PubMedGoogle Scholar
• Aedo S, Porcile A, Irribarra C. Calidad de vida relacionada con el climaterio en una población Chilena de mujeres saludables. Rev Chil Obstet Ginecol 2006;71:402–409.
   Google Scholar
• Chedraui P, Blümel JE, Baron G, Belzares E, Bencosme A, Calle A, Danckers L, Espinoza MT, Flores D, Gomez G, et al Impaired quality of life among middle aged women: A multicentre Latin American study. Maturitas 2008;61:323–329.
   PubMed Web of Science ®Google Scholar
• http://www.menopause-rating-scale.info/ Last accessed 30 July 2008.
   Google Scholar
• Heinemann LA, DoMinh T, Strelow F, Gerbsch S, Schnitker J, Schneider HP. The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study. Health Qual Life Outcomes 2004;2:67.
   PubMedGoogle Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62.
   PubMed Web of Science ®Google Scholar
• Williams JB. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 1989;45:742–747.
   Web of Science ®Google Scholar
• Ramos-Brieva JA, Cordero-Villafafila A. A new validation of the Hamilton Rating Scale for Depression. J Psychiatric Res 1988;22:21–28.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Handbook of psychiatric measures. Washington, DC: American Psychiatric Association; 2000.
   Google Scholar
• Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N. Executive summary: stages of Reproductive Aging Workshop (STRAW). Climacteric 2001;4:267–272.
   PubMedGoogle Scholar
• Schonberg MA, Wee CC. Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice. J Womens Health (Larchmt) 2005;14:507–514.
   PubMed Web of Science ®Google Scholar
• Pérez-Lopez FR, Chedraui P, Gilbert JJ, Pérez-Roncero G. Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women's Health Initiative era. Fertil Steril 2009;64:1171–1186.
   Google Scholar
• Ferrari A. Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms. J Obstet Gynaecol Res 2009;35:1083–1090.
   PubMed Web of Science ®Google Scholar
• Nahas EA, Nahas-Neto J, Orsatti FL, Carvalho EP, Oliveira ML, Dias R. Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study. Maturitas 2007;58:249–258.
   PubMed Web of Science ®Google Scholar
• Petri Nahas E, Nahás Neto J, De Luca L, Traiman P, Pontes A, Dalben I. Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy. Maturitas 2004;48:372–380.
   PubMed Web of Science ®Google Scholar
• Blumel JE, Castelo-Branco C, Rocangliolo ME, Bifa L, Tacla X, Mamani L. Changes in body mass index around menopause: a population study of Chilean woman. Menopause 2001;8:239–244.
   PubMed Web of Science ®Google Scholar
• Nachtigall LE, Baber RJ, Barentsen R, Durand N, Panay N, Pitkin J, van de Weijer PH, Wysocki S. Complementary and hormonal therapy for vasomotor symptom relief: a conservative clinical approach. J Obstet Gynaecol Can 2006 2006;28:279–289.
   PubMedGoogle Scholar
• Jacobs A, Wegewitz U, Sommerfeld C, Grossklaus R, Lampen A. Efficacy of isoflavones in relieving vasomotor menopausal symptoms - A systematic review. Mol Nutr Food Res 2009;53:1084–1097.
   PubMed Web of Science ®Google Scholar
• Lethaby AE, Brown J, Marjoribanks J, Kronenberg F, Roberts H, Eden J. Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database Syst Rev 2007;4: CD001395.
   Google Scholar
• Gambacciani M, Pepe A. Vasomotor symptoms and cardiovascular risk. Climacteric 2009;12:32–35.
   PubMed Web of Science ®Google Scholar
• Pinkerton JV, Stovall DW. Is there an association between vasomotor symptoms and both low bone density and cardiovascular risk? Menopause 2009;16:219–223.
   PubMed Web of Science ®Google Scholar
• Chedraui P, Hidalgo L, Chavez D, Morocho N, Alvarado M, Huc A. Menopausal symptoms and associated risk factors among postmenopausal women screened for the metabolic syndrome. Arch Gynecol Obstet 2007;275:161–168.
   PubMedGoogle Scholar
• Chedraui P, San Miguel G, Hidalgo L, Morocho N, Ross S. Effect of Trifolium pratense-derived isoflavones on the lipid profile of postmenopausal women with increased body mass index. Gynecol Endocrinol 2008;24:620–624.
   PubMed Web of Science ®Google Scholar
• Juliá-Mollá MD, García-Sánchez Y, Romeu Sarrió A, Pérez-López FR. Cimicifuga racemosa treatment and health related quality of life in postmenopausal Spanish women. Gynecol Endocrinol 2009;25:21–26.
   PubMed Web of Science ®Google Scholar
• Pérez-López FR, Chedraui P, Haya J, Cuadros JL. Effects of the Mediterranean diet on longevity and age-related morbid conditions. Maturitas 2009;64:67–79.
   PubMed Web of Science ®Google Scholar
• Llaneza P, Gonzalez C, Fernandez-Iñarrea J, Alonso A, Diaz-Fernandez MJ, Arnott I, Ferrer-Barriendos J. Soy isoflavones, Mediterranean diet, and physical exercise in postmenopausal women with insulin resistance. Menopause 2010;17:372–378.
   PubMed Web of Science ®Google Scholar
• Charles C, Yuskavage J, Carlson O, John M, Tagalicud AS, Maggio M, Muller DC, Egan J, Basaria S. Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women. Menopause 2009;16:395–400.
   PubMed Web of Science ®Google Scholar
• Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord 1993;29:85–96.
   PubMed Web of Science ®Google Scholar
• Barry KL, Fleming MF, Manwell LB, Copeland LA, Appel S. Prevalence of and factors associated with current and lifetime depression in older adult primary care patients. Fam Med 1998;30:366–371.
   PubMedGoogle Scholar
• Craig MC, Murphy DG. Estrogen: effects on normal brain function and neuropsychiatric disorders. Climacteric 2007;10: 97–104.
   PubMed Web of Science ®Google Scholar
• Joffe H, Hall JE, Soares CN, Hennen J, Reilly CJ, Carlson K, Cohen LS. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause 2002;9:392–398.
   PubMed Web of Science ®Google Scholar
• Juang KD, Wang SJ, Lu SR, Lee SJ, Fuh JL. Hot flashes are associated with psychological symptoms of anxiety and depression in peri- and post- but not premenopausal women. Maturitas 2005;52:119–126.
   PubMed Web of Science ®Google Scholar
• Chedraui P, Morales B, Hidalgo L. Depression and related risk factors among climacteric women Climacteric 2008;11: 125.
   Google Scholar
• Lipovac M, Chedraui P, Gruenhut C, Gocan A, Stammler M, Imhof M. Improvement of postmenopausal depressive and anxiety symptoms after treatment with isoflavones derived from red clover extracts. Maturitas 2010;65:258–261.
   PubMed Web of Science ®Google Scholar
• Bryant M, Cassidy A, Hill C, Powell J, Talbot D, Dye L. Effect of consumption of soy isoflavones on behavioural, somatic and affective symptoms in women with premenstrual syndrome. Br J Nutr 2005;93:731–739.
   PubMed Web of Science ®Google Scholar
• de Sousa-Muñoz RL, Filizola RG. Efficacy of soy isoflavones for depressive symptoms of the climacteric syndrome. Maturitas 2009;63:89–93.
   PubMed Web of Science ®Google Scholar
• Bu L, Lephart ED. Soy isoflavones modulate the expression of BAD and neuron-specific beta III tubulin in male rat brain. Neurosci Lett 2005;385:153–157.
   PubMedGoogle Scholar